Clinical Trials Browser

Completed × Recurrence × Denosumab × Clear all

NCT01624766 2021-02-25

Everolimus and Anakinra or Denosumab in Treating Participants With Relapsed or Refractory Advanced Cancers

Phase 1 Completed

Neoplasm Metastasis, Neoplasms, Recurrence

NCT03415477 2018-01-30

Deno-ABC

Phase 1/2 Completed

Fractures, Spontaneous, Neoplasms, Recurrence, Bone Cysts, Aneurysmal

NCT00259740 2017-03-15

Open-Label, Phase 2, Proof of Concept Study in Multiple Myeloma - Denosumab

Phase 2 Completed

96 enrolled 7 charts

Multiple Myeloma, Recurrence